# EFNB2

## Overview
Ephrin B2 (EFNB2) is a gene that encodes the transmembrane protein ephrin-B2, which is a key player in the ephrin-Eph signaling pathway. This pathway is integral to numerous physiological processes, including angiogenesis, neural development, and bone remodeling. Ephrin-B2 is characterized by its ability to engage in bidirectional signaling through interactions with Eph receptors, particularly EphB4, facilitating communication between cells and influencing cellular positioning and boundary formation. The protein's structure includes an ectodomain, a transmembrane domain, and a cytoplasmic domain, with a PDZ-binding motif that is crucial for reverse signaling. Ephrin-B2's role extends to various biological systems, such as the vascular, nervous, and skeletal systems, where it regulates processes like blood vessel formation, neural differentiation, and bone homeostasis. Additionally, ephrin-B2 is implicated in pathological conditions, including cancer progression and pain regulation, highlighting its significance in both health and disease (Matsuo2012Bone; Bonaparte2005EphrinB2; Kania2016Mechanisms).

## Structure
Ephrin B2 (EFNB2) is a transmembrane protein involved in cell signaling, particularly in angiogenesis and cardiac development. The primary structure of EFNB2 consists of 333 amino acids in humans, with a highly conserved sequence across mammalian species, sharing over 98% homology with murine ephrinB2 (Su2019Essential). The protein's domain structure includes an ectodomain, a transmembrane domain, and a cytoplasmic domain. The ectodomain spans residues 1-229 in humans and is responsible for receptor-ligand interactions (Su2019Essential). 

EFNB2's tertiary structure is characterized by a β-barrel conformation, which is crucial for its interaction with Eph receptors (Chrencik2006Structural). The protein also contains a PDZ-binding motif at its C-terminus, which is involved in reverse signaling pathways (Su2019Essential). Post-translational modifications include tyrosine phosphorylation, which plays a role in signaling cascades (Du2020The). 

EFNB2 is known to form dimers or higher-order oligomers as part of its quaternary structure, facilitating its role in cell-cell communication (Bonaparte2005EphrinB2). The protein's interaction with viral glycoproteins, such as those from Hendra and Nipah viruses, highlights its functional versatility and significance in host-pathogen interactions (Bonaparte2005EphrinB2).

## Function
Ephrin B2 (EFNB2) is a critical component of the ephrin-Eph signaling pathway, which plays a significant role in various physiological processes. In the vascular system, ephrin-B2 is essential for angiogenesis and lymphangiogenesis, where it helps establish boundaries between arterial and venous territories and is crucial for the formation of blood and lymphatic vessels (Kania2016Mechanisms). It is involved in the development of venous and lymphatic valves, indicating shared molecular regulators in these structures (Kania2016Mechanisms).

In bone biology, ephrin-B2 acts as a 'coupling stimulator' in bone remodeling by suppressing osteoclastic activity and enhancing osteoblastic activity through bidirectional signaling with EphB4, maintaining bone homeostasis (Matsuo2012Bone). It is upregulated in osteoclasts and osteoblasts, where it regulates bone resorption and formation, respectively (Matsuo2012Bone).

In the nervous system, ephrin-B2 is involved in neural development, particularly in maintaining neural stem cell quiescence and promoting neuronal differentiation (Kania2016Mechanisms). It also plays a role in synaptic plasticity by modulating calcium dynamics and synaptic morphology (Kania2016Mechanisms). Ephrin-B2's activity is primarily at cell membranes, facilitating cell-cell communication and influencing cell positioning and boundary formation (Bush2022Cellular).

## Clinical Significance
Mutations and alterations in the expression of the EFNB2 gene have been linked to several diseases and conditions. In the context of pain regulation, EFNB2 is upregulated in inflammatory and neuropathic pain conditions, leading to increased NMDA receptor NR2B phosphorylation and enhanced synaptic efficacy. This upregulation is associated with heightened pain sensitivity and spontaneous pain behavior, indicating its role in maintaining pain states (Zhao2010NociceptorExpressed).

In cardiovascular health, EFNB2 plays a significant role in blood pressure regulation. Studies have shown that EFNB2 deletion in vascular smooth muscle cells leads to reduced blood pressure in male mice, suggesting a protective effect against hypertension. This effect is sex-specific, as female mice did not exhibit the same reduction in blood pressure. Human genetic studies have identified SNPs in the EFNB2 gene associated with hypertension risk in males, particularly those with type 2 diabetes, indicating a potential link between EFNB2 mutations and hypertension (Wang2016Reduced).

In musculoskeletal development, cartilage-specific deletion of EFNB2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging. These mice exhibit reduced bone mineral density and joint degeneration, suggesting that EFNB2 is crucial for cartilage integrity and normal bone development (ValverdeFranco2016Cartilagespecific).

## Interactions
Ephrin B2 (EFNB2) is involved in various protein interactions that are crucial for its role in cellular signaling. EFNB2 interacts with EphB receptors, particularly EphB4, to regulate processes such as angiogenesis and cell migration. This interaction facilitates bidirectional signaling, where forward signaling involves the activation of EphB4, and reverse signaling involves EFNB2 activation (Du2020The). 

In vascular smooth muscle cells, EFNB2 modulates the internalization and signaling of the platelet-derived growth factor receptor beta (PDGFRβ). It influences the distribution of PDGFRβ in the plasma membrane and its endocytosis, acting as a molecular switch for downstream signaling pathways (Nakayama2013EphrinB2). 

EFNB2 also interacts with flotillin-1, which helps maintain its protein levels by preventing cleavage by the metalloprotease ADAM10. This interaction is significant in neural tube closure during embryogenesis, as flotillin-1 stabilizes EFNB2 expression, preventing defects in neural development (Ji2014EphrinB2). 

In the context of cancer, EFNB2 is implicated in chemoresistance and epithelial-to-mesenchymal transition in colorectal cancer, where it is a target of mutant p53. This interaction promotes tumorigenesis and chemoresistance through various signaling pathways (Alam2015DNA).


## References


[1. (Alam2015DNA) S K Alam, V K Yadav, S Bajaj, A Datta, S K Dutta, M Bhattacharyya, S Bhattacharya, S Debnath, S Roy, L A Boardman, T C Smyrk, J R Molina, S Chakrabarti, S Chowdhury, D Mukhopadhyay, and S Roychoudhury. Dna damage-induced ephrin-b2 reverse signaling promotes chemoresistance and drives emt in colorectal carcinoma harboring mutant p53. Cell Death &amp; Differentiation, 23(4):707–722, October 2015. URL: http://dx.doi.org/10.1038/cdd.2015.133, doi:10.1038/cdd.2015.133. This article has 78 citations.](https://doi.org/10.1038/cdd.2015.133)

[2. (Du2020The) Enming Du, Xue Li, Siyu He, Xiaohua Li, and Shikun He. The critical role of the interplays of ephrinb2/ephb4 and vegf in the induction of angiogenesis. Molecular Biology Reports, 47(6):4681–4690, June 2020. URL: http://dx.doi.org/10.1007/s11033-020-05470-y, doi:10.1007/s11033-020-05470-y. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-020-05470-y)

[3. (ValverdeFranco2016Cartilagespecific) Gladys Valverde-Franco, Bertrand Lussier, David Hum, Jiangping Wu, Adjia Hamadjida, Numa Dancause, Hassan Fahmi, Mohit Kapoor, Jean-Pierre Pelletier, and Johanne Martel-Pelletier. Cartilage-specific deletion of ephrin-b2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo. Arthritis Research &amp; Therapy, March 2016. URL: http://dx.doi.org/10.1186/s13075-016-0965-6, doi:10.1186/s13075-016-0965-6. This article has 9 citations.](https://doi.org/10.1186/s13075-016-0965-6)

[4. (Kania2016Mechanisms) Artur Kania and Rüdiger Klein. Mechanisms of ephrin–eph signalling in development, physiology and disease. Nature Reviews Molecular Cell Biology, 17(4):240–256, January 2016. URL: http://dx.doi.org/10.1038/nrm.2015.16, doi:10.1038/nrm.2015.16. This article has 517 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm.2015.16)

[5. (Ji2014EphrinB2) Yon Ju Ji, Yoo-Seok Hwang, Kathleen Mood, Hee-Jun Cho, Hyun-Shik Lee, Emily Winterbottom, Hélène Cousin, and Ira O. Daar. Ephrinb2 affects apical constriction in xenopus embryos and is regulated by adam10 and flotillin-1. Nature Communications, March 2014. URL: http://dx.doi.org/10.1038/ncomms4516, doi:10.1038/ncomms4516. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms4516)

[6. (Bush2022Cellular) Jeffrey O. Bush. Cellular and molecular mechanisms of EPH/EPHRIN signaling in evolution and development, pages 153–201. Elsevier, 2022. URL: http://dx.doi.org/10.1016/bs.ctdb.2022.02.005, doi:10.1016/bs.ctdb.2022.02.005. This article has 11 citations.](https://doi.org/10.1016/bs.ctdb.2022.02.005)

[7. (Wang2016Reduced) Yujia Wang, Pavel Hamet, Eric Thorin, Johanne Tremblay, John Raelson, Zenghui Wu, Hongyu Luo, Wei Jin, Julie L Lavoie, Junzheng Peng, Francois-Christophe Marois-Blanchet, Muhammad Ramzan Tahir, John Chalmers, Mark Woodward, Stephen Harrap, Shijie Qi, Charles Yibin Li, and Jiangping Wu. Reduced blood pressure after smooth muscle efnb2 deletion and the potential association of efnb2 mutation with human hypertension risk. European Journal of Human Genetics, 24(12):1817–1825, August 2016. URL: http://dx.doi.org/10.1038/ejhg.2016.105, doi:10.1038/ejhg.2016.105. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2016.105)

[8. (Matsuo2012Bone) Koichi Matsuo and Natsuko Otaki. Bone cell interactions through eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adhesion &amp; Migration, 6(2):148–156, March 2012. URL: http://dx.doi.org/10.4161/cam.20888, doi:10.4161/cam.20888. This article has 129 citations.](https://doi.org/10.4161/cam.20888)

[9. (Bonaparte2005EphrinB2) Matthew I. Bonaparte, Antony S. Dimitrov, Katharine N. Bossart, Gary Crameri, Bruce A. Mungall, Kimberly A. Bishop, Vidita Choudhry, Dimiter S. Dimitrov, Lin-Fa Wang, Bryan T. Eaton, and Christopher C. Broder. Ephrin-b2 ligand is a functional receptor for hendra virus and nipah virus. Proceedings of the National Academy of Sciences, 102(30):10652–10657, July 2005. URL: http://dx.doi.org/10.1073/pnas.0504887102, doi:10.1073/pnas.0504887102. This article has 362 citations.](https://doi.org/10.1073/pnas.0504887102)

[10. (Chrencik2006Structural) Jill E. Chrencik, Alexei Brooun, Michelle L. Kraus, Michael I. Recht, Anand R. Kolatkar, Gye Won Han, Jan Marcus Seifert, Hans Widmer, Manfred Auer, and Peter Kuhn. Structural and biophysical characterization of the ephb4·ephrinb2 protein-protein interaction and receptor specificity. Journal of Biological Chemistry, 281(38):28185–28192, September 2006. URL: http://dx.doi.org/10.1074/jbc.M605766200, doi:10.1074/jbc.m605766200. This article has 122 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M605766200)

[11. (Zhao2010NociceptorExpressed) Jing Zhao, Guanglu Yuan, Cruz M Cendan, Mohammed A Nassar, Malin C Lagerström, Klas Kullander, Isabella Gavazzi, and John N Wood. Nociceptor-expressed ephrin-b2 regulates inflammatory and neuropathic pain. Molecular Pain, 6:1744-8069-6–77, January 2010. URL: http://dx.doi.org/10.1186/1744-8069-6-77, doi:10.1186/1744-8069-6-77. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1744-8069-6-77)

[12. (Nakayama2013EphrinB2) Akiko Nakayama, Masanori Nakayama, Christopher J. Turner, Susanne Höing, John J. Lepore, and Ralf H. Adams. Ephrin-b2 controls pdgfrβ internalization and signaling. Genes &amp; Development, 27(23):2576–2589, December 2013. URL: http://dx.doi.org/10.1101/gad.224089.113, doi:10.1101/gad.224089.113. This article has 51 citations.](https://doi.org/10.1101/gad.224089.113)

[13. (Su2019Essential) Sheng-an Su, Yao Xie, Yuhao Zhang, Yutao Xi, Jie Cheng, and Meixiang Xiang. Essential roles of ephrinb2 in mammalian heart: from development to diseases. Cell Communication and Signaling, March 2019. URL: http://dx.doi.org/10.1186/s12964-019-0337-3, doi:10.1186/s12964-019-0337-3. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-019-0337-3)